Clinical trial
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal…
NCT00002399 · Schering-Plough, Industry · Completed
Key facts
| NCT number | NCT00002399 |
|---|---|
| Title | A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients |
| Official title | A Multicenter, Randomized, Double-Blind, Phase II Study to Evaluate the Safety, Tolerance and Efficacy of Multiple Doses of SCH 56592 Versus Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients |
| Lead sponsor | Schering-Plough, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Candidiasis, Oral, HIV Infections |
| Intervention type | Drug |
| Interventions | Posaconazole, Fluconazole |
| Enrollment | 500 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | Argentina, Belgium, Canada, Chile, Dominican Republic, Ethiopia, France, Germany, Guatemala, Honduras, Israel, Mexico and 6 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: